Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Current Opinion in Urology|February 18, 2017
Neurogenic voiding dysfunctionPetros Georgopoulos, Apostolos ApostolidisUrology Journal|November 22, 2021
DNA Hypermethylation af a Panel Of Genes as an Urinary Biomarker For Bladder Cancer DiagnosisPetros Georgopoulos, Maria Papaioannou, Soultana Markopoulou, et al.Biology|August 26, 2023
A Study of DNA Methylation of Bladder Cancer Biomarkers in the Urine of Patients with Neurogenic Lower Urinary Tract DysfunctionPeriklis Koukourikis, Maria Papaioannou, Petros Georgopoulos, et al.Current Drug Targets|May 19, 2015
Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?Apostolos ApostolidisExpert Opinion on Pharmacotherapy|February 4, 2011
Pharmacotherapy for overactive bladder: minimally invasive treatment -- botulinum toxinsApostolos ApostolidisEuropean Urology Focus|November 19, 2019
Neurourological Management After Failed Intradetrusor OnabotulinumtoxinA InjectionsApostolos Apostolidis, Anne P CameronCurrent Drug Targets|June 23, 2020
Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage FailuresApostolos Apostolidis, Efstathios Papaefstathiou, Sotirios GatsosNeurourology and Urodynamics|March 15, 2012
What determines whether a patient with LUTS seeks treatment? ICI-RS 2011Apostolos Apostolidis, Cosimo de Nunzio, Andrea TubaroEuropean Urology|January 24, 2006
Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivityApostolos Apostolidis, Prokar Dasgupta, Clare J FowlerPageof 9